tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Acurx to sell 2.745M shares at 40c in registered direct offering
The FlyAcurx to sell 2.745M shares at 40c in registered direct offering
5d ago
ACXP
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
13d ago
ACXP
ALLR
Acurx’s ibezapolstat shows efficacy in CDI treatment
PremiumThe Fly
Acurx’s ibezapolstat shows efficacy in CDI treatment
16d ago
ACXP
Acurx new patent granted by JPO related to DNA Polymerase IIIC Inhibitors
PremiumThe Fly
Acurx new patent granted by JPO related to DNA Polymerase IIIC Inhibitors
21d ago
ACXP
Acurx files to sell 2.61M shares of common stock for holders
PremiumThe Fly
Acurx files to sell 2.61M shares of common stock for holders
1M ago
ACXP
Acurx to sell 2.46M shares at $1.015 in registered direct offering
PremiumThe FlyAcurx to sell 2.46M shares at $1.015 in registered direct offering
2M ago
ACXP
Acurx receives positive EMA guidance for ibezapolstat Phase 3 program
Premium
The Fly
Acurx receives positive EMA guidance for ibezapolstat Phase 3 program
2M ago
ACXP
Acurx updates Phase 3 readiness for ibezapolstat in C. difficile Infection
Premium
The Fly
Acurx updates Phase 3 readiness for ibezapolstat in C. difficile Infection
3M ago
ACXP
Acurx board approves Bitcoin as treasury reserve asset
PremiumThe Fly
Acurx board approves Bitcoin as treasury reserve asset
4M ago
ACXP
Acurx supported, participated in Peggy Lillis CDI symposium
PremiumThe Fly
Acurx supported, participated in Peggy Lillis CDI symposium
4M ago
ACXP
Acurx Pharmaceuticals Reports Promising Q3 2024 Results
PremiumCompany Announcements
Acurx Pharmaceuticals Reports Promising Q3 2024 Results
4M ago
ACXP
Acurx reports Q3 EPS (17c) vs. (24c) last year
PremiumThe Fly
Acurx reports Q3 EPS (17c) vs. (24c) last year
4M ago
ACXP
Acurx’s ibezapostat shows favorable effect in Phase 2b CDI trial
PremiumThe FlyAcurx’s ibezapostat shows favorable effect in Phase 2b CDI trial
5M ago
ACXP
Acurx’s ibezapolstat shows positive results in CDI and Anthrax
Premium
The Fly
Acurx’s ibezapolstat shows positive results in CDI and Anthrax
6M ago
ACXP
Acurx announces results of Phase 2 ibezapolstat trial in C. difficile Infection
Premium
The Fly
Acurx announces results of Phase 2 ibezapolstat trial in C. difficile Infection
6M ago
ACXP
Acurx reports Q2 EPS (26c) vs (28c) last year
PremiumThe Fly
Acurx reports Q2 EPS (26c) vs (28c) last year
7M ago
ACXP
Acurx granted new patent for ibezapolstat to treat CDI
PremiumThe Fly
Acurx granted new patent for ibezapolstat to treat CDI
8M ago
ACXP
Acurx presents Phase 2 results of ibezapolstat in C. difficile Infection
PremiumThe Fly
Acurx presents Phase 2 results of ibezapolstat in C. difficile Infection
8M ago
ACXP
Acurx reports results from meeting with FDA regarding ibezapolstat
PremiumThe Fly
Acurx reports results from meeting with FDA regarding ibezapolstat
10M ago
ACXP
Acurx presents ibezapolstat Phase 2 clinical trial results in CDI
PremiumThe FlyAcurx presents ibezapolstat Phase 2 clinical trial results in CDI
10M ago
ACXP
Acurx price target lowered to $12 from $14 at H.C. Wainwright
Premium
The Fly
Acurx price target lowered to $12 from $14 at H.C. Wainwright
12M ago
ACXP
Acurx files common stock offering, no amount given
Premium
The Fly
Acurx files common stock offering, no amount given
12M ago
ACXP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >